Atlas Trials

A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects

Clinical trial NCT06549959 · RECRUITING

Trial details

NCT number
NCT06549959
Sponsor
RemeGen Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2024-08-05
Primary completion
2024-11-30
Enrollment
248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.